Q: Do you see the is­sue of drug pric­ing com­ing to a head? What do you ex­pect to hap­pen?

Modern Healthcare - - NEWS -

Stephen Ubl:

“It’s re­ally im­por­tant for us to get to the same fact ba­sis. We have a sit­u­a­tion where de­spite the fact drug spend­ing is go­ing up, it’s ac­tu­ally com­ing off this spike in 2014 and 2015, which was some­what anoma­lous.

“The hep­ati­tis C medicines came to the mar­ket, which we can ar­gue about the cost at launch, but through mar­ket com­pe­ti­tion and sev­eral other com­pa­nies now in that space prices have come down by around 60%. Even Ex­press Scripts and CVS would ar­gue that it’s cheaper to ac­quire So­valdi in the U.S. than it is in Western Europe, and it will dra­mat­i­cally re­duce in­ci­dence of liver can­cer hos­pi­tal­iza­tions.

“In 2014-15, you also had fewer drugs come off of patent than was his­tor­i­cally the case and you also had a record num­ber of Food and Drug Ad­min­is­tra­tion ap­provals of medicines. So what’s hap­pen­ing is (drug spend­ing is) com­ing back down and CMS’ own ac­tu­ar­ies pre­dict that will be in line with over­all health­care spend­ing in the next sev­eral years.”

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.